Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower ...
Brand-name drugs from companies that don't cut deals with the Trump administration in the coming months could face tariffs of ...
The White House announced new tariffs of up to 100% targeting brand-name drugs made by overseas manufacturers.